For the Quarter Ending December 2022
North America
North American region, primarily the United States market, displayed descending pricing sentiments for Bupropion throughout the final Quarter of 2022. At the start of the fourth quarter, the prices remained on the stable side as the demand remained dormant, following the trend of the previous month.
Market players continue to keep a close eye on various factors that have impacted the market of almost all commodities, including Bupropion. Till November, the prices remained sturdy, with moderate demand balanced with overall supplies within the domestic market. Following December, the cost of Bupropion declined considerably and got settled at USD 71850/ MT CFR Los Angeles.
Asia Pacific
The prices of Bupropion in the Asia Pacific region, majorly in China, demonstrated a significant dip with ending of the last Quarter of 2022. Government data showed the official manufacturing purchasing managers index (PMI) fell to 48.0 in November, slipping well below last month's reading of 49.2 as steadily rising COVID-19 cases in the fourth quarter caused further disruptions and the prices of all the commodities, including Bupropion. Due to restrictions on the export of all commodities, including Bupropion, China's main issue was managing congested logistics on the key trade channels to North America and Europe during November, which additionally affected the price trends of Bupropion. With the end of the fourth quarter of 2022, the prices of Bupropion got assembled at USD 71000/MT FOB Shanghai, with declining demand and stockpiling of inventories among the market players.
Europe
During the fourth quarter of 2022, the prices of Bupropion showed mixed market sentiments in the European region. October month witnessed a continuous decrement in end-user demand for Bupropion. Following November, the prices inclined considerably and got stable in December with the settlement of USD 75570/MT CFR Hamburg in Germany. Furthermore, Bupropion's price trend in Germany was supported by a rapid decline in supply chain interruption and shipping costs. However, as growing energy prices began to level down at the end of 2022, inflation in Europe declined in December for the second consecutive month. Due to a decline in international orders, notably from exporting nations like China, demand decreased from the previous month. However, the inventories, with market players', remained larger, and their inquiries weaker during the Thanksgiving break.
For the Quarter Ending September 2022
North America
The market trend for Bupropion experienced a declining price trajectory during the third Quarter of 2022, backed by weakened downstream demand in the domestic market. Furthermore, Bupropion was an Active Pharmaceutical Ingredients (API) whose imports into the US were severely affected due to China's zero-covid policy and worsened climatic conditions admitted to the hurricane. Also, various Chinese production activities were forced to shut down in the second half of Q3 due to the heat wave and a power constraint, which negatively affected US imports. Moreover, towards the termination of Q3, the prices witnessed a continuous decrease and settled at USD 185000/MT CFR Los Angeles.
APAC
In the APAC region, during the third quarter of 2022, the prices of Bupropion witnessed a fluctuating trend owing to variable downstream demand and the supply side. In the first half of q3, the prices rose significantly, leading to the shortage of stocks with the suppliers, which in turn propelled them to increase their quotation rates. Additionally, disrupted trading activities leading to delayed shipments and climatic variations were another factor that supported the market sentiments of Bupropion in the region. Furthermore, towards the termination of q3, the prices decreased considerably, backed by weaker demand and enough supplies, with the settlement of USD 176000 /MT FOB Shanghai.
Europe
The European region witnessed a similar market sentiment in the prices for Bupropion as the APAC region, owing to healthy downstream demand in the market during h1 of q3. Across Europe, rising energy costs due to the Russia-Ukraine conflict and the rerouting activities kept the market on a higher note. Additionally, delayed exports from China due to Covid restrictions and halted transportation resulted in low inventories in the regional market till the mid of q3. Towards the termination of q3, the prices for Bupropion dropped significantly owing to decremented demand for sufficient supplies with adequate suppliers. The prices witnessed in September for Bupropion settled at USD 200000 /MT CFR Hamburg.
For the Quarter Ending June 2022
North America
The North American region witnessed a declining pricing sentiment throughout the second quarter of 2022, backed by weaken offtake and sufficient inventories in the market. Furthermore, the prices went low owing to the consistent availability of Upstream feed Bromine and in-sufficient downstream demand from the market. Moreover, lessen queries from the Chinese market due to the C0VID-19 lockdown restriction and higher inflation pressure amid war led to a price decrement of Bupropion in US. The prices recorded at the end of second quarter was at USD 189000/MT CFR Houston with a declination of 0.34 percent. Additionally, fluctuating in the supply-demand gap throughout the second quarter kept the market sentiments of Bupropion on a weaker side.
Asia Pacific
During the second quarter, the prices of Bupropion witnessed an incremented state in the APAC region. Strong downstream demand was seen in Q2 with heightened prices of Bupropion. Consistent offtake and limited availability from end-user industries impacted the price trends of Bupropion. At the onset of Q2, the prices decreased due to the covid-restriction and affected production rate in the Chinese market admits deterred demand. Moreover, despite declining feedstock Bromine prices, the market price trend for Bupropion remained at a higher state owing to its surging demand and enough feedstock inventories to meet its demand. Further, with the end of April 2022, the prices surged consistently at a higher rate recorded at USD 181000/MT FOB Shanghai in the Chinese market.
Europe
The European market witnessed an Upward pricing trajectory with the settlement of USD 206000/MT CFR Hamburg during the second quarter of 2022 due to strong demand from end-user enterprises and a higher inflation rate. Furthermore, the supply disruption leading to the shortage of production activities and stock caused the traders and sellers in the region to offer the products at a reduced price to spot buyers. Increasing Russian-Ukraine geopolitical tension and rerouting transporting activities impacted the price trends of Bupropion in the European Region. Moreover, higher energy value results in uptrend pressure on input cost of feed Bromine resulting in the price enhancement of Bupropion further in the overall region.
